4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0000897069-26-001602
Chief Executive Officer acquired 1,600 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ng George K Chief Executive Officer | 2026-08-08 | Option exercise | +1,600 | 17,092 | D | ||
| Derivatives | |||||||
| Ng George K Chief Executive Officer | 2026-08-08 | Option exercise · Restricted Stock | −1,600 | 19,624 | D | ||
Loading xslF345X06/form4.xml…